2-(1-{6-[(2-[F-18]Fluoroethyl) (Methyl)Amino]-2-naphthyl} Ethylidene) Malononitrile-PET for in Vivo Diagnose of Tauopathy in Unclassified Parkinsonism

NCT02214862 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Progressive Supranuclear Palsy
Multi-System Atrophy
Parkinsonism

Interventions

DRUG: [F18]-FDDNP

Sponsor

Fundacion Clinic per a la Recerca Biomédica